• 復(fù)旦大學(xué)附屬華東醫(yī)院呼吸內(nèi)科（上海 200040）通訊作者：瞿介明，E-mail：jmqu64@yahoo.com.cn;

社區(qū)獲得性肺炎( CAP) 是嚴(yán)重威脅人類健康的常見疾病之一, 但在其診斷和治療仍存在相當(dāng)大的差異。臨床路徑( clinical pathway, CP) 是一種新的臨床診療規(guī)范管理方式,
近年來開始應(yīng)用于CAP 的臨床診治, 陸續(xù)有協(xié)會(huì)組織開始制定關(guān)于CAP 的臨床路徑, 并應(yīng)用于臨床。

引用本文： 朱迎鋼,瞿介明. 臨床路徑在社區(qū)獲得性肺炎中的應(yīng)用. 中國呼吸與危重監(jiān)護(hù)雜志, 2010, 9(1): 97-99. doi: 復(fù)制

1. Bartlett JG,Dowell SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America.Clin Infect Dis,2000,31:347-382.
2. Hauck LD,Adler LM,Mulla ZD.Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia.Ann Epidemiol,2004,14:669-675.
3. Lave JR,Lin CJ,Hughes CP,et al.The cost of treating patients with community-acquired pneumonia.Semin Respir Crit Care Med,1999,20:189-197.
4. 龔棣.介紹一種新的醫(yī)療護(hù)理模式——臨床路徑.現(xiàn)代醫(yī)院管理,2004,2:42-44.
5. 吳袁俞云,英立平.臨床路徑實(shí)施手冊(cè).北京:北京醫(yī)科大學(xué)出版社,2002.
6. 王冬,董軍,朱士俊.臨床路徑——臨床醫(yī)療的標(biāo)準(zhǔn)化管理模式.醫(yī)院管理論壇,2003,19:38-42.
7. Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.
8. Meehan TP,Weingarten SR,Holmboe ES,et al.A statewide initiative to improve the care of hospitalized pneumonia patients:The Connecticut Pneumonia Pathway Project.Am J Med,2001,111:203-210.
9. Marrie TJ,Lau CY,Wheeler SL,et al.A controlled trial of a critical pathway for treatment of community-acquired pneumonia.CAPITAL Study Investiga tors.Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.JAMA,2000,283:749-755.
10. Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part I:the nursing perspective.J Am Med Dir Assoc,2006,7:271-278.
11. Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part II:the administrators’ perspective and how it differs from nurses’ views.J Am Med Dir Assoc,2006,7:279-286.
12. 孫宏永,徐峰,徐志豪,等.社區(qū)獲得性肺炎臨床路徑的初步探討.浙江醫(yī)學(xué),2007,29:805-806.
13. Barlow G,Nathwani D,Williams F,et al.Reducing door-to-antibiotic time in community-acquired pneumonia:Controlled before-and-after evaluation and cost-effectiveness analysis.Thorax,2007,62:67-74.
14. Ramirez JA. Switch therapy in community-acquired pneumonia. Diagn Microbiol Infect Dis,1995,22: 219-223.
15. Moeller JJ,Ma M,Hernandez P,et al.Discharge Delay in Patients with Community-acquired Pneumonia Managed on a Critical Pathway.Can J Infect Dis Med Microbiol,2006,17:109-113.
16. Masotti L,Ceccarelli E,Cappelli R,et al.Length of hospitalization in elderly patients with community-acquired pneumonia.Aging (Milano),2000,12:35-41.
17. Brancati FL,Chow JW,Wagener MM,,et al.Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumonia.Lancet,1993,342:30-33.
18. Marrie TJ.Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.Chemotherapy,2004,50 suppl 1:11-15.
19. Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
20. Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clin Infect Dis,2007,44 Suppl 2:S27-72.
21. Moran G.Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.J Emerg Med,2006,30:377-387.
  1. 1. Bartlett JG,Dowell SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America.Clin Infect Dis,2000,31:347-382.
  2. 2. Hauck LD,Adler LM,Mulla ZD.Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia.Ann Epidemiol,2004,14:669-675.
  3. 3. Lave JR,Lin CJ,Hughes CP,et al.The cost of treating patients with community-acquired pneumonia.Semin Respir Crit Care Med,1999,20:189-197.
  4. 4. 龔棣.介紹一種新的醫(yī)療護(hù)理模式——臨床路徑.現(xiàn)代醫(yī)院管理,2004,2:42-44.
  5. 5. 吳袁俞云,英立平.臨床路徑實(shí)施手冊(cè).北京:北京醫(yī)科大學(xué)出版社,2002.
  6. 6. 王冬,董軍,朱士俊.臨床路徑——臨床醫(yī)療的標(biāo)準(zhǔn)化管理模式.醫(yī)院管理論壇,2003,19:38-42.
  7. 7. Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.
  8. 8. Meehan TP,Weingarten SR,Holmboe ES,et al.A statewide initiative to improve the care of hospitalized pneumonia patients:The Connecticut Pneumonia Pathway Project.Am J Med,2001,111:203-210.
  9. 9. Marrie TJ,Lau CY,Wheeler SL,et al.A controlled trial of a critical pathway for treatment of community-acquired pneumonia.CAPITAL Study Investiga tors.Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.JAMA,2000,283:749-755.
  10. 10. Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part I:the nursing perspective.J Am Med Dir Assoc,2006,7:271-278.
  11. 11. Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part II:the administrators’ perspective and how it differs from nurses’ views.J Am Med Dir Assoc,2006,7:279-286.
  12. 12. 孫宏永,徐峰,徐志豪,等.社區(qū)獲得性肺炎臨床路徑的初步探討.浙江醫(yī)學(xué),2007,29:805-806.
  13. 13. Barlow G,Nathwani D,Williams F,et al.Reducing door-to-antibiotic time in community-acquired pneumonia:Controlled before-and-after evaluation and cost-effectiveness analysis.Thorax,2007,62:67-74.
  14. 14. Ramirez JA. Switch therapy in community-acquired pneumonia. Diagn Microbiol Infect Dis,1995,22: 219-223.
  15. 15. Moeller JJ,Ma M,Hernandez P,et al.Discharge Delay in Patients with Community-acquired Pneumonia Managed on a Critical Pathway.Can J Infect Dis Med Microbiol,2006,17:109-113.
  16. 16. Masotti L,Ceccarelli E,Cappelli R,et al.Length of hospitalization in elderly patients with community-acquired pneumonia.Aging (Milano),2000,12:35-41.
  17. 17. Brancati FL,Chow JW,Wagener MM,,et al.Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumonia.Lancet,1993,342:30-33.
  18. 18. Marrie TJ.Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.Chemotherapy,2004,50 suppl 1:11-15.
  19. 19. Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
  20. 20. Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clin Infect Dis,2007,44 Suppl 2:S27-72.
  21. 21. Moran G.Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.J Emerg Med,2006,30:377-387.